𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

✍ Scribed by Steele, J C; Rao, A; Marsden, J R; Armstrong, C J; Berhane, S; Billingham, L J; Graham, N; Roberts, C; Ryan, G; Uppal, H


Book ID
109855502
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
661 KB
Volume
18
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Outpatient combination chemoimmunotherap
✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

Phase I study of intranodal delivery of
✍ Scott T. Tagawa; Peter Lee; Jolie Snively; William Boswell; Song Ounpraseuth; Sa πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

## Abstract ## BACKGROUND Based on the likelihood of transfecting large numbers of local antigen‐presenting cells, a Phase I study in patients with Stage IV melanoma was conducted to determine the practicality, toxicity of, and immune responses to repeated infusions into a groin lymph node of esca